S100A9 Maintains Myeloid-Derived Suppressor Cells in Chronic Sepsis by Inducing miR-21 and miR-181b
Document Type
Article
Publication Date
8-1-2019
Description
Myeloid-derived suppressor cells (MDSC)expand during sepsis, suppress both innate and adaptive immunity, and promote chronic immunosuppression, which characterizes the late/chronic phase of sepsis. We previously reported that the transcription factors Stat3 and C/EBPβ synergize to induces the expression of microRNA (miR)-21 and miR-181b to promote MDSC expansion in a mouse model of polymicrobial sepsis that progresses from an early/acute proinflammatory phase to a late/chronic immunosuppressive stage. We also showed that Gr1+CD11b+ cells, the precursors of MDSCs, from mice genetically deficient in the inflammatory protein S100A9 lack miR-21 or miR-181b in late sepsis, and are not immunosuppressive. In the present study, we show that S100A9 induces miR-21 and miR-181b during the late sepsis phase. We find that S100A9 associates with and stabilizes the Stat3-C/EBPβ protein complex that activates the miRNA promoters. Reconstituting Gr1+CD11b+ cells from S100A9 knockout mice with late sepsis with S100A9 protein restores the Stat3-C/EBPβ protein complex and miRNA expressions, and switches the Gr1+CD11b+ cells into the immunosuppressive, MDSC phenotype. Importantly, we find that this process requires IL-10 mediated signaling, which induces S100A9 translocation from the cytosol to the nucleus. These results demonstrate that S100A9 promotes MDSC expansion and immunosuppression in late/chronic sepsis by inducing the expression of miR-21 and miR-181b.
Citation Information
Alkhateeb, Tuqa; Kumbhare, Ajinkya; Bah, Isatou; Youssef, Dima; Yao, Zhi Q.; McCall, Charles E.; and El Gazzar, Mohamed. 2019. S100A9 Maintains Myeloid-Derived Suppressor Cells in Chronic Sepsis by Inducing miR-21 and miR-181b. Molecular Immunology. Vol.112 72-81. https://doi.org/10.1016/j.molimm.2019.04.019 PMID: 31078118 ISSN: 0161-5890